Andrew Quick - 01 Jul 2022 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Chief Technology Officer
Signature
/s/ Donna Shiroma, by power of attorney
Issuer symbol
RCEL
Transactions as of
01 Jul 2022
Transactions value $
$0
Form type
4
Filing time
06 Jul 2022, 18:54:49 UTC
Previous filing
07 Sep 2021
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +36K +342.38% 46.5K 01 Jul 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +20.7K $0.00 20.7K 01 Jul 2022 Common Stock 20.7K $4.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments beginning on August 20, 2023.
F2 Includes unvested Restricted Stock Units.
F3 These Stock Options vest in four equal annual installments beginning on August 20, 2023.